Haemophilus influenzae type b, commonly called Hib, is a type of bacteria that causes serious infections, particularly in children under 5 years old. Despite its name, it has nothing to do with influenza (the flu). The name dates back to the 1892 flu pandemic, when scientists mistakenly believed this bacterium was responsible. In reality, Hib is a leading cause of bacterial meningitis, pneumonia, and other invasive infections in young children, though widespread vaccination has reduced cases by more than 99% since the prevaccine era.
How Hib Spreads
Hib bacteria live in the nose and throat and spread through respiratory droplets when an infected or colonized person coughs, sneezes, or breathes near others. Many people carry the bacteria without ever getting sick, but they can still pass it along. In young children whose immune systems are still developing, the bacteria can move beyond the throat and into the bloodstream, where they cause what doctors call “invasive” disease.
The bacterium’s outer shell, a sugar-based capsule, is what makes it particularly dangerous. This capsule helps the bacteria evade the immune system, especially in children under 5 whose bodies haven’t yet learned to mount an effective defense against it. Children younger than 1 year old have the highest infection rates of any age group.
Infections Hib Can Cause
When Hib bacteria enter the bloodstream, they can settle in different parts of the body and trigger a range of serious conditions:
- Pneumonia: The most common presentation. It causes high fever, chills, productive cough, shortness of breath, chest pain, and extreme fatigue.
- Meningitis: An infection of the membranes surrounding the brain and spinal cord. Symptoms include fever, severe headache, sensitivity to light, nausea, vomiting, and a stiff neck. Up to 20% of children who survive Hib meningitis are left with permanent hearing loss or other lasting neurological damage.
- Epiglottitis: A dangerous swelling of the tissue at the back of the throat that can block the airway. This is a medical emergency.
- Bloodstream infection: Bacteria circulating in the blood can cause widespread inflammation and organ damage.
- Cellulitis: A skin and soft tissue infection that typically causes redness, swelling, and warmth in the affected area.
- Infectious arthritis: Painful swelling of one or more joints.
In infants, the signs are often harder to spot. Rather than the classic symptoms listed above, babies may simply seem unusually irritable, drowsy, or refuse to eat. Vomiting and poor feeding are common early warning signs.
Who Is Most at Risk
Two age groups face the greatest danger: children younger than 5 and adults 65 or older. Within the younger group, infants under 1 year carry the highest risk because their immune systems are the least equipped to fight off encapsulated bacteria like Hib.
Certain medical conditions also increase vulnerability at any age. People without a functioning spleen, whether removed surgically or non-functional due to sickle cell disease, lose a key part of the body’s defense against bacteria with capsules. HIV infection, immune deficiencies that affect antibody production, and cancers requiring treatments that suppress the immune system all raise the risk as well.
How Hib Is Diagnosed
Doctors confirm a Hib infection by growing the bacteria from a sample of blood, spinal fluid, or fluid from the infected site. Speed matters: the bacteria die quickly outside the body, so samples need to reach the lab fast. In cases of epiglottitis, blood cultures come back positive 70 to 90% of the time.
When meningitis is suspected, a spinal tap provides the most useful information. The spinal fluid typically shows high levels of white blood cells and elevated protein, while sugar levels drop below normal. Newer molecular tests can also identify Hib directly from samples and distinguish it from closely related, harmless species that look similar under a microscope.
Treatment for Invasive Hib Disease
Invasive Hib infections require hospital treatment with intravenous antibiotics. The specific antibiotic depends on which part of the body is infected and how the bacteria respond to testing. Some strains have developed resistance to older antibiotics, so lab testing helps guide the right choice. Epiglottitis often requires airway management alongside antibiotics, since throat swelling can progress rapidly. Recovery time varies depending on the type and severity of infection. Meningitis, for example, typically requires a longer hospital stay and close monitoring for complications like hearing loss.
The Hib Vaccine
The Hib conjugate vaccine is one of the most successful vaccines in modern medicine. Before it became available in the late 1980s, Hib was the leading cause of bacterial meningitis in American children. Since routine infant vaccination began, invasive Hib disease has dropped by more than 99%.
The standard schedule starts at 2 months of age, with the first dose given as early as 6 weeks. Depending on the vaccine brand, infants receive either two or three doses during the primary series between 2 and 6 months of age, followed by a booster dose between 12 and 15 months. The booster should be given at least 8 weeks after the most recent dose.
One of the vaccine’s most powerful effects goes beyond protecting the vaccinated child. By preventing the bacteria from colonizing the nose and throat, the vaccine reduces person-to-person transmission. This creates herd immunity: even unvaccinated children benefit because fewer people around them carry and spread the bacteria. Studies have found that in countries with routine Hib vaccination, carrier rates drop dramatically in both vaccinated and unvaccinated children. In one study of unvaccinated children in a population with high vaccine coverage, only 3.6% carried Hib in their throats.
Hib vs. Other Types of H. influenzae
Haemophilus influenzae comes in several forms. Six have a protective capsule (labeled types a through f), and many strains have no capsule at all, called nontypeable H. influenzae. Type b is by far the most dangerous of the encapsulated strains, historically responsible for the vast majority of severe invasive disease in children. The Hib vaccine specifically targets type b’s capsule and does not protect against other types or nontypeable strains, which tend to cause less severe infections like ear infections and bronchitis in adults with chronic lung disease.